Pharmacoinformatics and molecular dynamics simulation approach to identify anti-diarrheal potentials of Centella asiatica (L.) Urb. against Vibrio cholerae

Vibrio cholerae, the etiological agent of cholera, causes dehydration and severe diarrhea with the production of cholera toxin. Due to the acquired antibiotic resistance, V. cholerae has drawn attention to the establishment of novel medications to counteract the virulence and viability of the pathogen. Centella asiatica is a medicinal herb native to Bangladesh that has a wide range of medicinal and ethnobotanical applications including anti-bacterial properties. In the present investigation, a total of 25 bioactive phytochemicals of C. asiatica have been screened virtually through molecular docking, ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) analyses, and molecular dynamics simulation. Our results revealed four lead compounds as Viridiflorol (-8.7 Kcal/mol), Luteolin (-8.1 Kcal/mol), Quercetin (-8.0 Kcal/mol) and, Geranyl acetate (-7.1 Kcal/mol) against V. cholerae Toxin co-regulated pilus virulence regulatory protein (ToxT). All the lead compounds have been found to possess favorable pharmacokinetic, pharmacodynamics, and molecular dynamics properties. Toxicity analysis revealed satisfactory results with no major side effects. Molecular dynamics simulation was performed for 100 ns that revealed noteworthy conformational stability and structural compactness for all the lead compounds, especially for Quercetin. Target class prediction unveiled enzymes in most of the cases and some experimental and investigational drugs were found as structurally similar analogs of the lead compounds. These findings could aid in the development of novel therapeutics targeting Cholera disease and we strongly recommend in vitro trials of our experimental findings.Communicated by Ramaswamy H. Sarma.

[1]  M. A. Ali,et al.  Anticancer potential of phytochemicals from Oroxylum indicum targeting Lactate Dehydrogenase A through bioinformatic approach , 2022, Toxicology reports.

[2]  Shumneva Shrestha,et al.  Cholera amid COVID-19: Call from three nations; India, Bangladesh, and Nepal , 2022, Annals of Medicine and Surgery.

[3]  M. O. Rahman,et al.  Anti-angiogenic potential of bioactive phytochemicals from Helicteres isora targeting VEGFR-2 to fight cancer through molecular docking and molecular dynamics simulation , 2022, Journal of biomolecular structure & dynamics.

[4]  J. Ribeiro-Filho,et al.  Potentiation of the Activity of Antibiotics against ATCC and MDR Bacterial Strains with (+)-α-Pinene and (-)-Borneol , 2022, BioMed research international.

[5]  A. Vaziri,et al.  Global status of antimicrobial resistance among environmental isolates of Vibrio cholerae O1/O139: a systematic review and meta-analysis , 2022, Antimicrobial resistance and infection control.

[6]  G. Batiha,et al.  Ethnobotany, phytochemistry, pharmacology, and toxicity of Centella asiatica (L.) Urban: A comprehensive review , 2021, Phytotherapy research : PTR.

[7]  J. Mandal,et al.  In-vitro study of the effect of Centella asiatica on cholera toxin production and the gene expression level of ctxA gene in Vibrio cholerae isolates. , 2021, Journal of ethnopharmacology.

[8]  Mohammad Kawsar Sharif Siam,et al.  In silico drug design and molecular docking studies targeting Akt1 (RAC-alpha serine/threonine-protein kinase) and Akt2 (RAC-beta serine/threonine-protein kinase) proteins and investigation of CYP (cytochrome P450) inhibitors against MAOB (monoamine oxidase B) for OSCC (oral squamous cell carcinoma) , 2020, Journal of biomolecular structure & dynamics.

[9]  B. Salehi,et al.  Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications , 2020, BMC Complementary Medicine and Therapies.

[10]  F. Ameen,et al.  Gold nanoparticles synthesised by flavonoid tricetin as a potential antibacterial nanomedicine to treat respiratory infections causing opportunistic bacterial pathogens. , 2019, Microbial pathogenesis.

[11]  Kun Hu,et al.  Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson's disease model by activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway. , 2019, Toxicology and applied pharmacology.

[12]  Olivier Michielin,et al.  SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules , 2019, Nucleic Acids Res..

[13]  Zbigniew Dutkiewicz,et al.  Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors , 2018, Bioinorganic chemistry and applications.

[14]  Md Kamal Hossain,et al.  Molecular docking and dynamics of Nickel-Schiff base complexes for inhibiting β-lactamase of Mycobacterium tuberculosis , 2018, In Silico Pharmacology.

[15]  C. Lipinski,et al.  The rule of five should not impede anti-parasitic drug development , 2017, International journal for parasitology. Drugs and drug resistance.

[16]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[17]  T. Hagen,et al.  Demonstration of AutoDock as an Educational Tool for Drug Discovery. , 2017, Journal of chemical education.

[18]  Chuan-Tien Hung,et al.  Control of the negative IRES trans-acting factor KHSRP by ubiquitination , 2016, Nucleic acids research.

[19]  R. Kasimani,et al.  Comparative modelling and molecular docking of nitrate reductase from Bacillus weihenstephanensis (DS45) , 2016 .

[20]  Vincent Zoete,et al.  A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules , 2016, ChemMedChem.

[21]  Douglas E. V. Pires,et al.  pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures , 2015, Journal of medicinal chemistry.

[22]  Aditi Gangopadhyay,et al.  Identification of inhibitors against the potential ligandable sites in the active cholera toxin , 2015, Comput. Biol. Chem..

[23]  Vinícius Gonçalves Maltarollo,et al.  Applying machine learning techniques for ADME-Tox prediction: a review , 2015, Expert opinion on drug metabolism & toxicology.

[24]  Haruo Watanabe,et al.  Vibrio cholerae O1 El Tor and O139 Bengal Strains Carrying ctxBET, Bangladesh , 2013, Emerging infectious diseases.

[25]  Haruo Watanabe,et al.  Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011. , 2012, Journal of medical microbiology.

[26]  Marcus D. Hanwell,et al.  Avogadro: an advanced semantic chemical editor, visualization, and analysis platform , 2012, Journal of Cheminformatics.

[27]  R. Migliani,et al.  A cluster of acute diarrhea suspected to be cholera in French travelers in Haiti, December 2010. , 2012, Journal of travel medicine.

[28]  Pramod Kumar,et al.  Tetracycline resistant V. cholerae O1 biotype El Tor serotype Ogawa with classical ctxB from a recent cholera outbreak in Orissa, Eastern India. , 2012, Journal of infection and public health.

[29]  Suranjana Das,et al.  Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing , 2010, PloS one.

[30]  Firdausi Qadri,et al.  Clinical outcomes in household contacts of patients with cholera in Bangladesh. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Torsten Schwede,et al.  Automated comparative protein structure modeling with SWISS‐MODEL and Swiss‐PdbViewer: A historical perspective , 2009, Electrophoresis.

[32]  L. Singh,et al.  Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India. , 2008, International journal of antimicrobial agents.

[33]  Jing-Tao Wu,et al.  Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection. , 2005, Current topics in medicinal chemistry.

[34]  C. Lipinski Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[35]  A. Weintraub,et al.  Reemergence of Epidemic Vibrio cholerae O139, Bangladesh , 2003, Emerging infectious diseases.

[36]  V. DiRita,et al.  The Vibrio cholerae ToxR/TcpP/ToxT virulence cascade: distinct roles for two membrane‐localized transcriptional activators on a single promoter , 2000, Molecular microbiology.

[37]  A. Faruque,et al.  Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae 0139 synonym Bengal , 1993, The Lancet.

[38]  Amit Pal,et al.  Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India , 1993, The Lancet.